VivoSeq
Other

Cough Suppression

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Cough Suppression is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

3

clinical trials

Completed1 · 33%
Unknown status1 · 33%
Not yet recruiting1 · 33%

Clinical Trials

Trial Activity

A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy
Completed·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 2/3·NCT01955824·500 enrolled
Efficacy of Dexmedetomidine for Cough Suppression in Patients Undergoing Thyroid Surgery
Unknown status·—·Phase 4·NCT03312413·400 enrolled
A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy
Not yet recruiting·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 2/3·NCT06376942·1,050 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)